| Canertinib | IC50 | 10.0 [1], 14.0 [2], 27.0 [3], 31.0 [4] |
| Ibrutinib | IC50 | 0.1 [1], 1.8 [2] |
| Staurosporine | IC50 | 28.3 [1], 282.0 [2] |
| Dacomitinib | IC50 | 74.0 [1], 83.67 [2] |
| 2-PropenaMide, N-[cis-4-[4-aMino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-1-yl]cyclohexyl]- | IC50 | 3.2 [1] |
| Gefitinib | IC50 | 476.0 [1] |
| Erlotinib | IC50 | 1130.0 [1] |
| Lapatinib | IC50 | 1000.0 [1] |
| Doramapimod | IC50 | 30000.0 [1] |
| Dacomitinib monohydrate | IC50 | 74.0 [1] |
| Nvp-aew541 | IC50 | 1700.0 [1] |
| 4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline | IC50 | 12.0 [1] |
| Cfms Receptor Tyrosine Kinase Inhibitor | IC50 | 24000.0 [1] |
| N-(4-((3-Bromophenyl)amino)quinazolin-6-yl)but-2-ynamide | IC50 | 12.0 [1] |
| N6,N6-Dimethyl-N4-[1-(phenylmethyl)-5-indazolyl]pyrido[3,4-d]pyrimidine-4,6-diamine | IC50 | 20.0 [1] |
| Tak-285 | IC50 | 260.0 [1] |
| Bms-599626 | IC50 | 190.0 [1] |
| N-(2,6-Difluorophenyl)-5-[3-[2-[5-ethyl-2-methoxy-4-[4-(4-methylsulfonylpiperazin-1-yl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide | IC50 | 25000.0 [1] |
| PD-153035 hydrochloride | IC50 | 49.0 [1] |
| 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one | IC50 | 25200.0 [1] |
| Evobrutinib | IC50 | 37.9 [1] |
| EGFR Inhibitor | IC50 | 7640.0 [1] |
| EGFR/ErbB-2/ErbB-4 Inhibitor | IC50 | 0.5 [1] |
| 4-Tert-Butyl-N-[6-(1h-Imidazol-1-Yl)imidazo[1,2-A]pyridin-2-Yl]benzamide | IC50 | 19952.62 [1] |
| N~3~-Cyclopropyl-N~4~'-(Cyclopropylmethyl)-6-Methylbiphenyl-3,4'-Dicarboxamide | IC50 | 25000.0 [1] |
| CID 44814409 | IC50 | 10000.0 [1] |
| 2-(4-Fluorophenyl)-3-(4-pyridinyl)pyrazolo[1,5-a]pyridine | IC50 | 10000.0 [1] |
| 2-Methyl-N-[2-[3-[[2-(prop-2-enoylamino)acetyl]amino]anilino]pyrimidin-5-yl]-5-[[3-(trifluoromethyl)benzoyl]amino]benzamide | IC50 | 3.3 [1] |
| 6,6-Dimethyl-8-[1-(oxan-4-ylmethyl)piperidin-4-yl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile | IC50 | 213.0 [1] |
| JAK3 covalent inhibitor-1 | IC50 | 10000.0 [1] |
| 4-Amino-5-chloro-6-ethoxy-pyridine-2-carboxylic acid 4-methanesulfonyl-benzylamide | Ki | 3800.0 [1] |
| 7-Chloro-3-oxo-8-(1,3-thiazol-5-ylmethylamino)-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5,7,9,17(21),18-hexaene-18-carbonitrile | Ki | 3750.0 [1] |
| 1-({4-[(3,4-Dichlorophenyl)methoxy]phenyl}methyl)azetidine-3-carboxylic acid | IC50 | 10000.0 [1] |
| 2-Methyl-N-[2-[3-(prop-2-enoylamino)anilino]pyrimidin-5-yl]-5-[[3-(trifluoromethyl)benzoyl]amino]benzamide | IC50 | 5.5 [1] |
| 7-Chloro-8-(3-hydroxypropoxy)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaene-19-carbonitrile | Ki | 10000.0 [1] |
| 7-Chloro-8-(3-hydroxypropyl)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile | Ki | 10000.0 [1] |
| N-(7-Chloro-19-cyano-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaen-8-yl)methanesulfonamide | Ki | 10000.0 [1] |
| [6-Chloro-4-methyl-3-[[3-(methylsulfamoylamino)phenyl]methyl]-2-oxochromen-7-yl] N,N-dimethylcarbamate | IC50 | 50000.0 [1] |
| 5-(2-Aminoethyl)-7-(7-(benzo[b]thiophen-2-yl)-1H-indazol-5-yl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine | IC50 | 10000.0 [1] |
| N-[3-[5-[2-(3-Morpholin-4-ylanilino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-phenylacetamide | IC50 | 18.0 [1] |
| CID 46927672 | IC50 | 10.0 [1] |
| N-[[2-[4-Amino-6-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]pyrimidin-5-yl]-1,3-oxazol-4-yl]methyl]prop-2-enamide | IC50 | 4.0 [1] |
| 1-(4-Fluorophenyl)-N-[3-fluoro-4-(5-phenylthieno[2,3-d]pyrimidin-4-yl)oxyphenyl]-2-oxopyridine-3-carboxamide | IC50 | 10000.0 [1] |
| 1-[5-Tert-butyl-3-[4-[2-(dimethylamino)ethyl]-5-oxo-1,4-diazepane-1-carbonyl]thiophen-2-yl]-3-(2,3-dichlorophenyl)urea | IC50 | 30000.0 [1] |
| 9-Cyclopentyl-N2-[4-(4-methylpiperazin-1-yl)phenyl]-N8-phenyl-purine-2,8-diamine | IC50 | 30.0 [1] |
| (E)-4-(Dimethylamino)-N-[7-fluoro-4-(2-methylanilino)imidazo[1,5-a]quinoxalin-8-yl]-N-methylbut-2-enamide | IC50 | 43.7 [1] |
| 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
| 6-(6-Fluoroindol-1-yl)-2-[2-[7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyethyl]pyridazin-3-one | IC50 | 1000.0 [1] |
| N-Cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide | IC50 | 25000.0 [1] |
| N-[4-Methyl-3-[2-methyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-2-pyrrolidin-1-ylpyridine-4-carboxamide | IC50 | 25000.0 [1] |
| N-[4-(3-Chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-[di(propan-2-yl)amino]but-2-ynamide | IC50 | 538.0 [1] |
| N-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]-4-morpholin-4-ylbut-2-ynamide | IC50 | 229.0 [1] |
| N-[4-(3-Chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-5-(4-methylpiperazin-1-yl)pent-2-ynamide | IC50 | 1.2 [1] |
| N-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]-4-(dibutylamino)but-2-ynamide | IC50 | 624.0 [1] |
| N-[4-(3-Chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]hept-2-ynamide | IC50 | 7.1 [1] |
| N-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]-5-(diethylamino)pent-2-ynamide | IC50 | 16.0 [1] |
| N-[4-(3-Chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-morpholin-4-ylbut-2-ynamide | IC50 | 6.2 [1] |
| N-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]-4-(diethylamino)but-2-ynamide | IC50 | 310.0 [1] |
| N-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-morpholinyl)-2-pentynamide | IC50 | 1.0 [1] |
| N-[4-[(3-Chloro-4-fluorophenyl)amino]-6-quinazolinyl]-5-(4-morpholinyl)-2-pentynamide | IC50 | 4.3 [1] |
| N-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]-4-hydroxybut-2-ynamide | IC50 | 7.3 [1] |
| N-[4-(3-Chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-5-piperidin-1-ylpent-2-ynamide | IC50 | 1.8 [1] |
| N-[4-(3-Bromo-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-5-(4-methylpiperazin-1-yl)pent-2-ynamide | IC50 | 0.8 [1] |
| N-[4-(3-Chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]hex-2-ynamide | IC50 | 2.4 [1] |
| N-[4-(3-Chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-(dibutylamino)but-2-ynamide | IC50 | 73.0 [1] |
| 6,7-Diethoxy-N-(3-iodophenyl)quinazolin-4-amine;hydrochloride | IC50 | 59.0 [1] |
| 6,7-Diethoxy-N-[(4-fluorophenyl)methyl]quinazolin-4-amine | IC50 | 100.0 [1] |
| N-[4-(3-Chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-(diethylamino)but-2-ynamide | IC50 | 644.0 [1] |
| N-[4-(3-Bromo-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-5-morpholin-4-ylpent-2-ynamide | IC50 | 1.0 [1] |
| N-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]-4-[di(propan-2-yl)amino]but-2-ynamide | IC50 | 11.0 [1] |
| 2,3-Dimethyl-4-[2-methyl-3-(prop-2-enoylamino)phenyl]-1H-indole-7-carboxamide | IC50 | 240.0 [1] |
| 4-[3-(Ethenylsulfonylamino)-2-methylphenyl]-2,3-dimethyl-1H-indole-7-carboxamide | IC50 | 10.0 [1] |
| 6-[4-[(5-Tert-butyl-1,2-oxazol-3-yl)carbamoylamino]phenyl]-N-[3-(dimethylamino)propyl]imidazo[2,1-b][1,3]thiazole-3-carboxamide | IC50 | 10000.0 [1] |
| N-(3-Chloro-4-fluorophenyl)-6-(1-methylpyrazol-4-yl)quinazolin-4-amine | IC50 | 801.0 [1] |
| 6-(1-Piperidin-4-ylpyrazol-4-yl)-N-quinolin-6-ylquinazolin-4-amine | IC50 | 1100.0 [1] |
| 6-(1-Methylpyrazol-4-yl)-N-quinolin-6-ylquinazolin-4-amine | IC50 | 930.0 [1] |
| N-(3-Ethynylphenyl)-6-(1-methylpyrazol-4-yl)quinazolin-4-amine | IC50 | 782.0 [1] |
| N-(3-Chloro-4-fluorophenyl)-6-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-4-amine | IC50 | 1603.0 [1] |
| Chmfl-egfr-202 | IC50 | 3.2 [1] |
| 7-(2-Hydroxypropan-2-yl)-4-[2-methyl-3-(prop-2-enoylamino)phenyl]-6,7,8,9-tetrahydro-5H-carbazole-1-carboxamide | IC50 | 150.0 [1] |
| (E)-N-[4-[(1-Benzylindazol-5-yl)amino]-7-(2-methoxyethoxy)quinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide | IC50 | 2.0 [1] |
| (E)-N-[4-[(1-Benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-morpholin-4-ylbut-2-enamide | IC50 | 6.0 [1] |
| (E)-N-[4-(4-Phenoxyanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide | IC50 | 2.0 [1] |
| (E)-N-[4-[[1-(Benzenesulfonyl)indol-5-yl]amino]-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide | IC50 | 10.0 [1] |
| (E)-N-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrido[3,4-d]pyrimidin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide | IC50 | 5.0 [1] |
| N-[4-[(1-Benzyl-2,3-dihydroindol-5-yl)amino]-7-methoxyquinazolin-6-yl]propanamide | IC50 | 82.0 [1] |
| (E)-N-[4-[[1-(Benzenesulfonyl)indol-5-yl]amino]-7-ethoxyquinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide | IC50 | 11.0 [1] |
| (E)-N-[4-(3-Chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-piperidin-1-ylbut-2-enamide | IC50 | 7.0 [1] |
| N-[7-Methoxy-4-(4-phenylmethoxyanilino)quinazolin-6-yl]propanamide | IC50 | 460.0 [1] |
| (E)-N-[7-Methoxy-4-[4-(pyridin-2-ylmethyl)anilino]quinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide | IC50 | 13.0 [1] |
| (E)-N-[4-[(1-Benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide | IC50 | 3.0 [1] |
| (E)-N-[4-[[1-(Benzenesulfonyl)indol-5-yl]amino]-7-ethoxyquinazolin-6-yl]-4-morpholin-4-ylbut-2-enamide | IC50 | 27.0 [1] |
| N-[4-(3-Chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]propanamide | IC50 | 376.0 [1] |
| N-[7-Methoxy-4-[[1-(pyridin-2-ylmethyl)indazol-5-yl]amino]quinazolin-6-yl]propanamide | IC50 | 15.0 [1] |
| (E)-4-(4-Methylpiperazin-1-yl)-N-[4-[4-(pyridin-2-ylmethyl)anilino]pyrido[3,4-d]pyrimidin-6-yl]but-2-enamide | IC50 | 94.0 [1] |
| (E)-N-[7-Ethoxy-4-[4-(pyridin-2-ylmethoxy)anilino]quinazolin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-enamide | IC50 | 94.0 [1] |
| (E)-N-[4-[(1-Benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-enamide | IC50 | 4.0 [1] |
| (E)-N-[4-(3-Chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-enamide | IC50 | 302.0 [1] |
| (E)-N-[4-[(1-Benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide | IC50 | 4.0 [1] |
| N-[7-Methoxy-4-[[1-(pyridin-4-ylmethyl)indol-5-yl]amino]quinazolin-6-yl]propanamide | IC50 | 213.0 [1] |